Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Biomed Pharmacother. 2011 May 30;65(4):293–297. doi: 10.1016/j.biopha.2011.03.009

Fig. 3.

Fig. 3

Inhibition of PKA abrogates nuclear accumulation of pCREB-1α,Δ. Nuclear pCREB-1 levels increase in response to forskolin stimulation for 1 h. This response is partly abrogated by pretreatment with H-89 (2.34-fold). pCREB-1 levels are not affected by pretreatment with other kinase inhibitors. Samples treated with inhibitors alone exhibit no significant change in comparison to untreated cells (data not shown).